{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:14:23Z","timestamp":1790284463085,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s44313-025-00108-z","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:04:25Z","timestamp":1762877065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Beyond anemia: unraveling neutrophil defects and infection susceptibility in \u03b2-Thalassemia"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1707-372X","authenticated-orcid":false,"given":"Chingiz","family":"Asadov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1751-3684","authenticated-orcid":false,"given":"Gunay","family":"Aliyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"108_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","volume":"391","author":"AT Taher","year":"2018","unstructured":"Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391:155\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(17)31822-6.","journal-title":"Lancet"},{"key":"108_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMRA2021838","volume":"384","author":"AT Taher","year":"2021","unstructured":"Taher AT, Musallam KM, Cappellini MD. \u03b2-Thalassemias. N Engl J Med. 2021;384:727\u201343. https:\/\/doi.org\/10.1056\/NEJMRA2021838.","journal-title":"N Engl J Med"},{"key":"108_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/GIM.2016.173","volume":"19","author":"R Origa","year":"2017","unstructured":"Origa R. \u03b2-Thalassemia. Genet Med. 2017;19:609\u201319. https:\/\/doi.org\/10.1038\/GIM.2016.173.","journal-title":"Genet Med"},{"key":"108_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/HEM3.70095","volume":"9","author":"KM Musallam","year":"2025","unstructured":"Musallam KM, Cappellini MD, Porter JB, Farmakis D, Eleftheriou A, Angastiniotis M, et al. TIF guidelines for the management of transfusion-dependent \u03b2-thalassemia. Hemasphere. 2025;9:e70095. https:\/\/doi.org\/10.1002\/HEM3.70095.","journal-title":"Hemasphere"},{"key":"108_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/J.IJID.2015.09.001","volume":"39","author":"N Teawtrakul","year":"2015","unstructured":"Teawtrakul N, Jetsrisuparb A, Sirijerachai C, Chansung K, Wanitpongpun C. Severe bacterial infections in patients with non-transfusion-dependent thalassemia: prevalence and clinical risk factors. Int J Infect Dis. 2015;39:53\u20136. https:\/\/doi.org\/10.1016\/J.IJID.2015.09.001.","journal-title":"Int J Infect Dis"},{"key":"108_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1196\/annals.1345.006","volume":"1054","author":"C Borgna-Pignatti","year":"2005","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40\u20137. https:\/\/doi.org\/10.1196\/annals.1345.006.","journal-title":"Ann N Y Acad Sci"},{"key":"108_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1196\/ANNALS.1345.067","volume":"1054","author":"V Ladis","year":"2005","unstructured":"Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci. 2005;1054:445\u201350. https:\/\/doi.org\/10.1196\/ANNALS.1345.067.","journal-title":"Ann N Y Acad Sci"},{"key":"108_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/PBC.21028","volume":"48","author":"JPS Chern","year":"2007","unstructured":"Chern JPS, Su S, Lin KH, Chang SH, Lu MY, Jou ST, et al. Survival, mortality, and complications in patients with \u03b2-thalassemia major in northern Taiwan. Pediatr Blood Cancer. 2007;48:550\u20134. https:\/\/doi.org\/10.1002\/PBC.21028.","journal-title":"Pediatr Blood Cancer"},{"key":"108_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/00043426-200011000-00027","volume":"22","author":"W Wanachiwanawin","year":"2000","unstructured":"Wanachiwanawin W. Infections in e-\u03b2 thalassemia. Am J Pediatr Hematol\/Oncol. 2000;22:581\u20137. https:\/\/doi.org\/10.1097\/00043426-200011000-00027.","journal-title":"Am J Pediatr Hematol\/Oncol"},{"key":"108_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13054-016-1250-4","volume":"20","author":"PHC Leliefeld","year":"2016","unstructured":"Leliefeld PHC, Wessels CM, Leenen LPH, Koenderman L, Pillay J. The role of neutrophils in immune dysfunction during severe inflammation. Critical Care. 2016;20:1\u20139. https:\/\/doi.org\/10.1186\/S13054-016-1250-4.","journal-title":"Critical Care."},{"key":"108_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/J.IMMUNI.2010.11.011\/ASSET\/CED5681E-6BBB-475C-9B98-FD4D822BE9DD\/MAIN.ASSETS\/GR2.JPG","volume":"33","author":"N Borregaard","year":"2010","unstructured":"Borregaard N. Neutrophils, from marrow to microbes. Immunity. 2010;33:657\u201370. https:\/\/doi.org\/10.1016\/J.IMMUNI.2010.11.011\/ASSET\/CED5681E-6BBB-475C-9B98-FD4D822BE9DD\/MAIN.ASSETS\/GR2.JPG.","journal-title":"Immunity"},{"key":"108_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/J.BLRE.2012.09.001","volume":"26","author":"EE Gardiner","year":"2012","unstructured":"Gardiner EE, Andrews RK. Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction. Blood Rev. 2012;26:255\u20139. https:\/\/doi.org\/10.1016\/J.BLRE.2012.09.001.","journal-title":"Blood Rev"},{"key":"108_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.smim.2003.10.001","volume":"16","author":"S Akira","year":"2004","unstructured":"Akira S. Toll receptor families: structure and function. Semin Immunol. 2004;16:1\u20132. https:\/\/doi.org\/10.1016\/j.smim.2003.10.001.","journal-title":"Semin Immunol"},{"key":"108_CR14","first-page":"40","volume":"18","author":"IT Sharabchiev","year":"1973","unstructured":"Sharabchiev IT, Faradzheva KI, Samedov AS. Nonspecific immunobiological reactivity in children with homozygote beta thalassemia - PubMed. Probl Gematol Pereliv Krovi. 1973;18:40\u20134.","journal-title":"Probl Gematol Pereliv Krovi"},{"key":"108_CR15","unstructured":"Asadov CD, Kozinets GI. Functional activity of segmented-nuclei neutrophils in beta-thalassemia. Lab Delo. 1983:23\u20136."},{"key":"108_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000206875","volume":"69","author":"A Samy Khalifa","year":"1983","unstructured":"Samy Khalifa A, Abdel Fattah S, Maged Z, Sabry F, Ahmed Mohamed H. Immunoglobulin levels, opsonic activity and phagocytic power in Egyptian thalassemic children. Acta Haematol. 1983;69:136\u20139. https:\/\/doi.org\/10.1159\/000206875.","journal-title":"Acta Haematol"},{"issue":"1","key":"108_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/J.1365-2141.1993.TB08659.X","volume":"85","author":"Y Matzner","year":"1993","unstructured":"Matzner Y, Goldfarb A, Abrahamov A, Drexler R, Friedberg A, Rachmilewitz EA. Impaired neutrophil chemotaxis in patients with thalassaemia major. Br J Haematol. 1993;85(1):153\u20138. https:\/\/doi.org\/10.1111\/J.1365-2141.1993.TB08659.X.","journal-title":"Br J Haematol"},{"key":"108_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/08880019609030822","volume":"13","author":"N Kutukculer","year":"1996","unstructured":"Kutukculer N, Kutlu O, Nisli G, Oztop S, Cetingul N, Caglayan S. Assessment of neutrophil chemotaxis and random migration in children with thalassemia major. Pediatr Hematol Oncol. 1996;13:239\u201345. https:\/\/doi.org\/10.3109\/08880019609030822.","journal-title":"Pediatr Hematol Oncol"},{"key":"108_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/S002770100355\/METRICS","volume":"80","author":"DS Kyriakou","year":"2001","unstructured":"Kyriakou DS, Alexandrakis MG, Kyriakou ES, Liapi D, Kourelis TV, Passam F, et al. Activated peripheral blood and endothelial cells in thalassemia patients. Ann Hematol. 2001;80:577\u201383. https:\/\/doi.org\/10.1007\/S002770100355\/METRICS.","journal-title":"Ann Hematol"},{"key":"108_CR20","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/S00277-020-04213-0\/METRICS","volume":"99","author":"B Buttari","year":"2020","unstructured":"Buttari B, Profumo E, Caprari P, Massimi S, Sorrentino F, Maffei L, et al. Phenotypical and functional abnormalities of circulating neutrophils in patients with \u03b2-thalassemia. Ann Hematol. 2020;99:2265\u201377. https:\/\/doi.org\/10.1007\/S00277-020-04213-0\/METRICS.","journal-title":"Ann Hematol"},{"key":"108_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/S10238-015-0361-6\/METRICS","volume":"16","author":"KI Elsayh","year":"2016","unstructured":"Elsayh KI, Mohammed WS, Zahran AM, Saad K. Leukocytes apoptosis and adipocytokines in children with beta thalassemia major. Clin Exp Med. 2016;16:345\u201350. https:\/\/doi.org\/10.1007\/S10238-015-0361-6\/METRICS.","journal-title":"Clin Exp Med"},{"key":"108_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5812\/jpr.14508","volume":"6","author":"A Bazi","year":"2018","unstructured":"Bazi A, Shahramian I, Yaghoobi H, Naderi M, Azizi H. The role of immune system in thalassemia major: a narrative review. J Pediatr Rev. 2018;6:29\u201336. https:\/\/doi.org\/10.5812\/jpr.14508.","journal-title":"J Pediatr Rev"},{"issue":"3","key":"108_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/J.1365-2141.2005.05463.X","volume":"129","author":"J Amer","year":"2005","unstructured":"Amer J, Fibach E. Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta-thalassaemia patients. Br J Haematol. 2005;129(3):435\u201341. https:\/\/doi.org\/10.1111\/J.1365-2141.2005.05463.X.","journal-title":"Br J Haematol"},{"key":"108_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/BJH.12076","volume":"160","author":"PB Walter","year":"2013","unstructured":"Walter PB, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, et al. Increased leucocyte apoptosis in transfused \u03b2-thalassaemia patients. Br J Haematol. 2013;160:399\u2013403. https:\/\/doi.org\/10.1111\/BJH.12076.","journal-title":"Br J Haematol"},{"key":"108_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/416291a","volume":"416","author":"EP Reeves","year":"2002","unstructured":"Reeves EP, Lu H, Jacobs HL, Messina CGM, Bolsover S, Gabellall G, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002;416:291\u20137. https:\/\/doi.org\/10.1038\/416291A;KWRD=SCIENCE.","journal-title":"Nature"},{"key":"108_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/J.MICINF.2003.09.009","volume":"5","author":"D Roos","year":"2003","unstructured":"Roos D, Van Bruggen R, Meischl C. Oxidative killing of microbes by neutrophils. Microbes Infect. 2003;5:1307\u201315. https:\/\/doi.org\/10.1016\/J.MICINF.2003.09.009.","journal-title":"Microbes Infect"},{"key":"108_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1034\/J.1600-0609.2003.00011.X","volume":"70","author":"J Amer","year":"2003","unstructured":"Amer J, Goldfarb A, Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol. 2003;70:84\u201390. https:\/\/doi.org\/10.1034\/J.1600-0609.2003.00011.X.","journal-title":"Eur J Haematol"},{"issue":"1","key":"108_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/AJH.2830350104","volume":"35","author":"B Cantinieaux","year":"1990","unstructured":"Cantinieaux B, Hariga C, Fondu P, Ferster A, Toppet M. Desferrioxamine improves neutrophil phagocytosis in thalassemia major. Am J Hematol. 1990;35(1):13\u20137. https:\/\/doi.org\/10.1002\/AJH.2830350104.","journal-title":"Am J Hematol"},{"issue":"2","key":"108_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134\u201347. https:\/\/doi.org\/10.1038\/NRI.2017.105;SUBJMETA=1699,223,249,250,2504,254,631;KWRD=IMMUNOLOGICAL+DISORDERS,INFECTION,NEUTROPHILS","journal-title":"Nat Rev Immunol"},{"key":"108_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-06036-7","volume":"12","author":"R Thubthed","year":"2022","unstructured":"Thubthed R, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, Pattanapanyasat K, Vadolas J, et al. Impaired neutrophil extracellular trap formation in \u03b2-thalassaemia\/HbE. Sci Rep. 2022;12:1\u20138. https:\/\/doi.org\/10.1038\/s41598-022-06036-7.","journal-title":"Sci Rep"},{"key":"108_CR31","doi-asserted-by":"publisher","unstructured":"Sae-Khow K, Charoensappakit A, Leelahavanichkul A. Neutrophil diversity (Immature, Aged, and Low-Density Neutrophils) and functional plasticity: possible impacts of iron overload in \u03b2-Thalassemia. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/IJMS251910651","DOI":"10.3390\/IJMS251910651"},{"key":"108_CR32","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1182\/BLOOD-2016-07-730135","volume":"129","author":"P Siwaponanan","year":"2017","unstructured":"Siwaponanan P, Siegers JY, Ghazali R, Ng T, Mccoll B, Ng GZW, et al. Reduced PU.1 expression underlies aberrant neutrophil maturation and function in \u03b2-thalassemia mice and patients. Blood. 2017;129:3087\u201399. https:\/\/doi.org\/10.1182\/BLOOD-2016-07-730135.","journal-title":"Blood"},{"key":"108_CR33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1182\/BLOOD.V92.5.1576","volume":"92","author":"KL Anderson","year":"1998","unstructured":"Anderson KL, Smith KA, Pio F, Torbett BE, Maki RA. Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood. 1998;92:1576\u201385. https:\/\/doi.org\/10.1182\/BLOOD.V92.5.1576.","journal-title":"Blood"},{"key":"108_CR34","doi-asserted-by":"publisher","unstructured":"Li SN, Valante AJ, Qiang M, Schlegel W, Gamez M, Clark RA. Multiple PU.1 sites cooperate in the regulation ofp40phox transcription during granulocytic differentiation of myeloid cells. Blood. 2002;99:4578\u201387. https:\/\/doi.org\/10.1182\/BLOOD.V99.12.4578.","DOI":"10.1182\/BLOOD.V99.12.4578"},{"key":"108_CR35","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1084\/JEM.20050075","volume":"201","author":"A Dakic","year":"2005","unstructured":"Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005;201:1487\u2013502. https:\/\/doi.org\/10.1084\/JEM.20050075.","journal-title":"J Exp Med"},{"issue":"10","key":"108_CR36","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nm.3936","volume":"21","author":"B Will","year":"2015","unstructured":"Will B, Vogler TO, Narayanagari S, Bartholdy B, Todorova TI, Da Silva Ferreira M, et al. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia. Nat Med. 2015;21(10):1172\u201381. https:\/\/doi.org\/10.1038\/nm.3936.","journal-title":"Nat Med"},{"key":"108_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2174\/156652408786241384","volume":"8","author":"E Fibach","year":"2008","unstructured":"Fibach E, Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr Mol Med. 2008;8:609\u201319. https:\/\/doi.org\/10.2174\/156652408786241384.","journal-title":"Curr Mol Med"},{"key":"108_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/1024533031000081414","volume":"8","author":"E Wiener","year":"2003","unstructured":"Wiener E. Impaired phagocyte antibacterial effector functions in \u03b2-thalassemia: a likely factor in the increased susceptibility to bacterial infections. Hematology. 2003;8:35\u201340. https:\/\/doi.org\/10.1080\/1024533031000081414.","journal-title":"Hematology"},{"key":"108_CR39","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1182\/BLOOD.V104.11.3775.3775","volume":"104","author":"B Atasever","year":"2004","unstructured":"Atasever B, Kuruca SE, Karakas Z, Agaoglu L. In vitro modulation of cellular immunity with antioxidants in patients with thalassemia major. Blood. 2004;104:3775. https:\/\/doi.org\/10.1182\/BLOOD.V104.11.3775.3775.","journal-title":"Blood"},{"key":"108_CR40","doi-asserted-by":"publisher","unstructured":"Asadov C. Immunologic abnormalities in \u03b2-thalassemia. Blood Disord Transfus. 2014;5. https:\/\/doi.org\/10.37247\/PAI.1.2020.1A.","DOI":"10.37247\/PAI.1.2020.1A"},{"key":"108_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/J.1600-0609.1987.TB00159.X;PAGE:STRING:ARTICLE\/CHAPTER","volume":"39","author":"B Cantinieaux","year":"1987","unstructured":"Cantinieaux B, Hariga C, Ferster A, de Maertelaere E, Toppet M, Fondu P. Neutrophil dysfunctions in thalassaemia major: the role of cell iron overload. Eur J Haematol. 1987;39:28\u201334. https:\/\/doi.org\/10.1111\/J.1600-0609.1987.TB00159.X;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"Eur J Haematol"},{"key":"108_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0022-2143(99)90066-5","volume":"133","author":"B Cantinieaux","year":"1999","unstructured":"Cantinieaux B, Janssens A, Boelaert JR, Lejeune M, Vermylen C, Kerrels V, et al. Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis. J Lab Clin Med. 1999;133:353\u201361. https:\/\/doi.org\/10.1016\/S0022-2143(99)90066-5.","journal-title":"J Lab Clin Med"},{"issue":"2","key":"108_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/THALASSREP15020004","volume":"15","author":"S Santhakumar","year":"2025","unstructured":"Santhakumar S, Stephen L, Barade A, Kulkarni U, George B, Edison ES. Dysregulation of iron homeostasis in \u03b2-thalassemia and impaired neutrophil activity. Thalassemia Rep. 2025;15(2):4. https:\/\/doi.org\/10.3390\/THALASSREP15020004.","journal-title":"Thalassemia Rep"},{"key":"108_CR44","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1160\/TH04-04-0234\/ID\/JR0234-4\/BIB","volume":"92","author":"J Amer","year":"2004","unstructured":"Amer J, Fibach E. Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost. 2004;92:1052\u20139. https:\/\/doi.org\/10.1160\/TH04-04-0234\/ID\/JR0234-4\/BIB.","journal-title":"Thromb Haemost"},{"key":"108_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/1071576031000060607;CTYPE:STRING:JOURNAL","volume":"37","author":"N Phumala","year":"2003","unstructured":"Phumala N, Porasuphatana S, Unchern S, Pootrakul P, Fucharoen S, Chantharaksri U. Hemin: a possible cause of oxidative stress in blood circulation of \u03b2-thalassemia\/hemoglobin E disease. Free Radic Res. 2003;37:129\u201335. https:\/\/doi.org\/10.1080\/1071576031000060607;CTYPE:STRING:JOURNAL.","journal-title":"Free Radic Res"},{"issue":"12","key":"108_CR46","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ni.3590","volume":"17","author":"R Martins","year":"2016","unstructured":"Martins R, Maier J, Gorki AD, Huber KVM, Sharif O, Starkl P, et al. Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions. Nat Immunol. 2016;17(12):1361\u201372. https:\/\/doi.org\/10.1038\/ni.3590.","journal-title":"Nat Immunol"},{"issue":"2","key":"108_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/J.1462-5822.2008.01261.X","volume":"11","author":"SW Chung","year":"2009","unstructured":"Chung SW, Hall SR, Perrella MA. Role of haem oxygenase-1 in microbial host defence. Cell Microbiol. 2009;11(2):199\u2013207. https:\/\/doi.org\/10.1111\/J.1462-5822.2008.01261.X.","journal-title":"Cell Microbiol"},{"key":"108_CR48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/ANNUREV.PHARMTOX.010909.105600","volume":"50","author":"R Gozzelino","year":"2010","unstructured":"Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010;50:323\u201354. https:\/\/doi.org\/10.1146\/ANNUREV.PHARMTOX.010909.105600.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"108_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-67346-2","volume":"10","author":"A Nithichanon","year":"2020","unstructured":"Nithichanon A, Tussakhon I, Samer W, Kewcharoenwong C, Ato M, Bancroft GJ, et al. Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes. Sc Rep. 2020;10:1\u201312. https:\/\/doi.org\/10.1038\/s41598-020-67346-2.","journal-title":"Sc Rep"},{"key":"108_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1182\/BLOOD-2017-07-798728","volume":"131","author":"D Garcia-Santos","year":"2018","unstructured":"Garcia-Santos D, Hamdi A, Saxova Z, Fillebeen C, Pantopoulos K, Horvathova M, et al. Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a \u03b2-thalassemia mouse model. Blood. 2018;131:236\u201346. https:\/\/doi.org\/10.1182\/BLOOD-2017-07-798728.","journal-title":"Blood"},{"key":"108_CR51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3324\/HAEMATOL.11755","volume":"93","author":"PB Walter","year":"2008","unstructured":"Walter PB, Macklin EA, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, et al. Inflammation and oxidant-stress in \u03b2-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica. 2008;93:817\u201325. https:\/\/doi.org\/10.3324\/HAEMATOL.11755.","journal-title":"Haematologica"},{"key":"108_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.69923\/38127291","volume":"2","author":"SM Mohsen","year":"2025","unstructured":"Mohsen SM. Association between pro-inflammatory cytokines and some viral infections in Beta-thalassemia patients. Iraqi J Appl Sci. 2025;2:63\u201370. https:\/\/doi.org\/10.69923\/38127291.","journal-title":"Iraqi J Appl Sci"},{"key":"108_CR53","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.3390\/JCM10132872","volume":"10","author":"C Vanhaver","year":"2021","unstructured":"Vanhaver C, van der Bruggen P, Bruger AM. MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer. J Clin Med. 2021;10:2872. https:\/\/doi.org\/10.3390\/JCM10132872.","journal-title":"J Clin Med"},{"key":"108_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2020.00017\/XML","volume":"8","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Liu S, Zhang B, Qiao L, Zhang Y, Zhang Y. T cell dysfunction and exhaustion in cancer. Front Cell Dev Biol. 2020;8:502919. https:\/\/doi.org\/10.3389\/FCELL.2020.00017\/XML.","journal-title":"Front Cell Dev Biol"},{"key":"108_CR55","first-page":"431","volume":"80","author":"F Dore","year":"1995","unstructured":"Dore F, Bonfigli S, Pardini S, Longinotti M. Serum interleukin-8 levels in thalassemia intermedia. Haematologica. 1995;80:431\u20133.","journal-title":"Haematologica"},{"key":"108_CR56","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.4049\/JIMMUNOL.166.5.3476","volume":"166","author":"G Salamone","year":"2001","unstructured":"Salamone G, Giordano M, Trevani AS, Gamberale R, Vermeulen M, Schettinni J, et al. Promotion of neutrophil apoptosis by TNF-\u03b1. J Immunol. 2001;166:3476\u201383. https:\/\/doi.org\/10.4049\/JIMMUNOL.166.5.3476.","journal-title":"J Immunol"},{"key":"108_CR57","first-page":"21","volume":"4","author":"R Miniero","year":"1982","unstructured":"Miniero R, Canducci E, Ghigo D, Saracco P, Vullo C. Vitamin E in beta-thalassemia. Acta Vitaminol Enzymol. 1982;4:21\u20135.","journal-title":"Acta Vitaminol Enzymol"},{"key":"108_CR58","doi-asserted-by":"publisher","unstructured":"D\u2019Arqom A, Putri MG, Savitri Y, Rahul Alfaidin AM. Vitamin and mineral supplementation for \u03b2-thalassemia during COVID-19 pandemic. Future Sci OA. 2020;6. https:\/\/doi.org\/10.2144\/FSOA-2020-0110.","DOI":"10.2144\/FSOA-2020-0110"},{"key":"108_CR59","doi-asserted-by":"publisher","unstructured":"Ghazaiean M, Aliasgharian A, Karami H, Ghasemi MM, Darvishi-Khezri H. Antioxidative effects of N-acetylcysteine in patients with \u03b2\u2013thalassemia: a quick review on clinical trials. Health Sci Rep. 2024;7. https:\/\/doi.org\/10.1002\/HSR2.70096","DOI":"10.1002\/HSR2.70096"},{"key":"108_CR60","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/S00277-011-1404-Z\/TABLES\/1","volume":"91","author":"E Nur","year":"2012","unstructured":"Nur E, Brandjes DP, Teerlink T, Otten HM, Oude Elferink RPJ, Muskiet F, et al. N-acetylcysteine reduces oxidative stress in sickle cell patients. Ann Hematol. 2012;91:1097\u2013105. https:\/\/doi.org\/10.1007\/S00277-011-1404-Z\/TABLES\/1.","journal-title":"Ann Hematol"},{"key":"108_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPH.0000000000002291","volume":"44","author":"EK Goldberg","year":"2022","unstructured":"Goldberg EK, Lal A, Fung EB. Nutrition in Thalassemia: A Systematic Review of Deficiency, Relations to Morbidity, and Supplementation Recommendations. J Pediatr Hematol Oncol. 2022;44:1. https:\/\/doi.org\/10.1097\/MPH.0000000000002291.","journal-title":"J Pediatr Hematol Oncol"},{"key":"108_CR62","doi-asserted-by":"publisher","DOI":"10.12691\/JFNR-6-10-9","volume":"6","author":"EK Goldberg","year":"2018","unstructured":"Goldberg EK, Neogi S, Lal A, Higa A, Fung E. Nutritional deficiencies are common in patients with transfusion-dependent thalassemia and associated with iron overload. J Food Nutr Res (Newark). 2018;6:674. https:\/\/doi.org\/10.12691\/JFNR-6-10-9.","journal-title":"J Food Nutr Res (Newark)"},{"key":"108_CR63","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/S10787-022-00993-1","volume":"30","author":"G Mostafa-Hedeab","year":"2022","unstructured":"Mostafa-Hedeab G, Al-kuraishy HM, Al-Gareeb AI, Jeandet P, Saad HM, Batiha GES. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19. Inflammopharmacology. 2022;30:799. https:\/\/doi.org\/10.1007\/S10787-022-00993-1.","journal-title":"Inflammopharmacology"},{"key":"108_CR64","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/NDT\/GFR579","volume":"27","author":"L Gonz\u00e1lez-Espinoza","year":"2012","unstructured":"Gonz\u00e1lez-Espinoza L, Rojas-Campos E, Medina-P\u00e9rez M, Pe\u00f1a-Quintero P, G\u00f3mez-Navarro B, Cueto-Manzano AM. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial. Nephrol Dial Transplant. 2012;27:2023\u20138. https:\/\/doi.org\/10.1093\/NDT\/GFR579.","journal-title":"Nephrol Dial Transplant"},{"key":"108_CR65","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/BJH.18508","volume":"200","author":"S Siriworadetkun","year":"2023","unstructured":"Siriworadetkun S, Thiengtavor C, Thubthed R, Paiboonsukwong K, Fucharoen S, Pattanapanyasat K, et al. A comprehensive study of immune function and immunophenotyping of white blood cells from \u03b2-thalassaemia\/HbE patients on hydroxyurea supports the safety of the drug. Br J Haematol. 2023;200:367\u201376. https:\/\/doi.org\/10.1111\/BJH.18508.","journal-title":"Br J Haematol"},{"key":"108_CR66","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2009.028","volume":"1","author":"BM Ricerca","year":"2009","unstructured":"Ricerca BM, Girolamo AD, Rund D. Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. Mediterr J Hematol Infect Dis. 2009;1:e2009028. https:\/\/doi.org\/10.4084\/MJHID.2009.028.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"108_CR67","unstructured":"Alzhrani FS, Algethmi FA, Makin MA, Barayan NA, Hilal RM, Alnakhli SM. Prevalence and risk factors of severe bacterial infections in thalassemia patients.\u00a0Curr Pediatr Res.\u00a02020;24(7):264\u20139."},{"key":"108_CR68","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/14653240902849788","volume":"11","author":"CD Fitzhugh","year":"2009","unstructured":"Fitzhugh CD, Hsieh MM, Bolan CD, Saenz C, Tisdale JF. Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium? Cytotherapy. 2009;11:464. https:\/\/doi.org\/10.1080\/14653240902849788.","journal-title":"Cytotherapy"},{"key":"108_CR69","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/mt.2011.195","volume":"20","author":"E Yannaki","year":"2012","unstructured":"Yannaki E, Papayannopoulou T, Jonlin E, Zervou F, Karponi G, Xagorari A, et al. Hematopoietic stem cell mobilization for gene therapy of adult patients with severe \u0392-thalassemia results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects. Mol Ther. 2012;20:230\u20138. https:\/\/doi.org\/10.1038\/mt.2011.195.","journal-title":"Mol Ther"},{"issue":"16","key":"108_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS13164205","volume":"13","author":"M Sereno","year":"2021","unstructured":"Sereno M, Jimenez-Gordo AM, Baena-Espinar J, Aguado C, Mielgo X, Pertejo A, et al. A multicenter analysis of the outcome of cancer patients with neutropenia and COVID-19 optionally treated with granulocyte-colony stimulating factor (G-CSF): a comparative analysis. Cancers. 2021;13(16):4205. https:\/\/doi.org\/10.3390\/CANCERS13164205.","journal-title":"Cancers"},{"key":"108_CR71","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3324\/HAEMATOL.2022.282612","volume":"108","author":"A Tefferi","year":"2023","unstructured":"Tefferi A, Pardanani A, Gangat N. Momelotinib (JAK1\/JAK2\/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis. Haematologica. 2023;108:2919. https:\/\/doi.org\/10.3324\/HAEMATOL.2022.282612.","journal-title":"Haematologica"},{"key":"108_CR72","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2024-205767","volume":"144","author":"P Bose","year":"2024","unstructured":"Bose P, Gerds AT, Gupta V, Strouse B, Patel B, Ellis C, et al. Odyssey: a phase 2 open-label study of momelotinib in combination with luspatercept in patients with transfusion-dependent myelofibrosis. Blood. 2024;144:3191.2-3191.2. https:\/\/doi.org\/10.1182\/BLOOD-2024-205767.","journal-title":"Blood"},{"key":"108_CR73","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3324\/HAEMATOL.2023.284078","volume":"109","author":"P Bose","year":"2024","unstructured":"Bose P, Masarova L, Pemmaraju N, Bledsoe SD, Daver NG, Jabbour EJ, et al. Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study. Haematologica. 2024;109:2660\u20134. https:\/\/doi.org\/10.3324\/HAEMATOL.2023.284078.","journal-title":"Haematologica"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-025-00108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44313-025-00108-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-025-00108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:04:36Z","timestamp":1762877076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44313-025-00108-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1007\/s44313-025-00108-z","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}